Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2025BMC Pulmonary MedicineOpen Access

A novel disulfidptosis-related mRNA signature predicts prognosis and therapeutic response in lung squamous cell carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

WBWei BaiNJNing JiangYDYuhan Deng

Discussion

Loading...

Member takes

Overview

This research identifies disulfidptosis-related genes' prognostic value in lung squamous cell carcinoma, suggesting new therapeutic targets.

Key Points

  • A novel 9-gene signature predicts survival outcomes in lung squamous cell carcinoma, highlighting prognostic value.
  • Analysis of transcriptomic data identified 9 disulfidptosis-related genes significantly associated with patient survival.
  • Multivariate Cox regression developed a risk score model that effectively stratifies patients based on prognosis.
  • Findings underline the clinical relevance of disulfidptosis and present potential biomarkers for therapeutic targeting.

Cite This Study

Bai et al. (2025) studied this question.

synapsesocial.com/papers/68e9435d2d5336d28fb289c2https://doi.org/10.1186/s12890-025-03920-6
View Full Paper
Ask AI
Bookmark
Share